Delivery Order SPE2DB22D3016-SPE2DB24FBFW4

Award Date 9/3/24
Potential Completion Date 9/24/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of TIVDAK 40 MG VIALS, a pharmaceutical product, and has a ceiling value of $23,912.58. The contract is a firm-fixed price delivery order with an ultimate completion date of October 7, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is part...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of TIVDAK 40 MG VIALS. The contract has a ceiling value of $11,956.29 and a completion date of October 10, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other federal healthcare providers. This contract is part of...
This is a $11,956.29 firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of TIVDAK 40 MG VIALS, a medication, with an ultimate completion date of August 12, 2024. The contract has no set-aside designation. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation for...
This is a Delivery Order contract award to Amerisourcebergen Drug Corp Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of TIVDAK 40 MG VIALS. The contract is a Firm Fixed Price agreement with a ceiling value of $11,956.29 and an ultimate completion date of September 3, 2024. The contract is not designated as a set-aside. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian agencies to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,083.75, is for the delivery of 40 mg vials of the drug TIVDAK. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 28, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products, including the drug TIVDAK 40 MG VIALS. The award has a ceiling value of $27,898.01 and a completion date of November 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $11,956.29 Delivery Order contract is for the supply of the pharmaceutical product TIVDAK 40 MG VIALS. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $11,956.29 firm fixed price delivery order is for the supply of 40 mg vials of the drug TIVDAK. The award has an ultimate completion date of May 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FASD0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,083.75 firm fixed-price delivery order is for the supply of 4567682283 TIVDAK 40 MG VIALS. The contract has an ultimate completion date of April 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Delivery Order (DO) awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The DO, valued at $39,854.30, is for the supply of TIVDAK 40 MG VIALS, a specialty medication. This DO is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBFW4
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $11,956.29, is for the supply of TIVDAK 40 MG VIALS, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of September 24, 2024. There is no set-aside designation for this award. AmerisourceBergen Drug Corp's Corporate Office Division holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, to provide a comprehensive range of medical commodities to support military treatment programs, federal healthcare providers, and law enforcement agencies nationwide.

Generated 12/3/24, 9:44 AM